Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Neurocrine Biosciences and Arena establish research collaboration

Sep. 17, 1999

New transdermal drug delivery system receives U.S. patent coverage

Sep. 16, 1999

Diversa awarded SBIR grants

Sep. 15, 1999

Novel photoprobe for locating sites of action of general anesthetics

Sep. 14, 1999

CAT and AstraZeneca form antibody research collaboration

Sep. 9, 1999

Novartis initiates clinical trials using Emisphere's oral drug delivery technology

Sep. 9, 1999

Lexicon Genetics grants sublicense to Avatar BioSci for use of gene-trapping technology

Sep. 9, 1999

Theratechnologies and Atrix sign bone research collaboration

Sep. 9, 1999

Potent, selective human beta3-adrenoceptor antagonists discovered at Merck & Co.

Sep. 7, 1999

Celera Genomics and Gemini Research establish research collaboration

Sep. 7, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...